These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36873015)

  • 1. Pseudouridimycin-A Potent Nucleoside Inhibitor of the RNA Polymerase Beta Prime Subunit of
    Pavundurai Chandra K; Perumal D; Ragunathan P
    ACS Omega; 2023 Feb; 8(8):7989-8000. PubMed ID: 36873015
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibacterial Nucleoside-Analog Inhibitor of Bacterial RNA Polymerase.
    Maffioli SI; Zhang Y; Degen D; Carzaniga T; Del Gatto G; Serina S; Monciardini P; Mazzetti C; Guglierame P; Candiani G; Chiriac AI; Facchetti G; Kaltofen P; Sahl HG; Dehò G; Donadio S; Ebright RH
    Cell; 2017 Jun; 169(7):1240-1248.e23. PubMed ID: 28622509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbes, not humans: exploring the molecular basis of Pseudouridimycin selectivity towards bacterial and not human RNA polymerase.
    Rabbad AH; Agoni C; Olotu FA; Soliman ME
    Biotechnol Lett; 2019 Jan; 41(1):115-128. PubMed ID: 30377869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous Expression of Pseudouridimycin and Description of the Corresponding Minimal Biosynthetic Gene Cluster.
    Böhringer N; Patras MA; Schäberle TF
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33478059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the Pseudouridimycin Biosynthetic Pathway Provides Insights into the Formation of C-nucleoside Antibiotics.
    Sosio M; Gaspari E; Iorio M; Pessina S; Medema MH; Bernasconi A; Simone M; Maffioli SI; Ebright RH; Donadio S
    Cell Chem Biol; 2018 May; 25(5):540-549.e4. PubMed ID: 29551347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery, properties, and biosynthesis of pseudouridimycin, an antibacterial nucleoside-analog inhibitor of bacterial RNA polymerase.
    Maffioli SI; Sosio M; Ebright RH; Donadio S
    J Ind Microbiol Biotechnol; 2019 Mar; 46(3-4):335-343. PubMed ID: 30465105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of C-nucleoside Antimicrobials from Streptomyces albus DSM 40763: Strepturidin is Pseudouridimycin.
    Rosenqvist P; Palmu K; Prajapati RK; Yamada K; Niemi J; Belogurov GA; Metsä-Ketelä M; Virta P
    Sci Rep; 2019 Jun; 9(1):8935. PubMed ID: 31222036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Insights into the Role of Pseudouridimycin Binding in Disruption of Bacterial RNA Polymerase Bridge Helix Conformational Arrangement.
    H Rabbad A; Agoni C; E Soliman M
    Curr Pharm Biotechnol; 2023; 24(4):562-569. PubMed ID: 35546759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Genomic Molecular Epidemiological Study of Macrolide-Resistant Streptococcus pyogenes in Iceland, 1995 to 2016: Identification of a Large Clonal Population with a
    Southon SB; Beres SB; Kachroo P; Saavedra MO; Erlendsdóttir H; Haraldsson G; Yerramilli P; Pruitt L; Zhu L; Musser JM; Kristinsson KG
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32522827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of the antibacterial activity of a novel peptide deformylase inhibitor, GSK1322322.
    O'Dwyer K; Hackel M; Hightower S; Hoban D; Bouchillon S; Qin D; Aubart K; Zalacain M; Butler D
    Antimicrob Agents Chemother; 2013 May; 57(5):2333-42. PubMed ID: 23478958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of antimicrobial and bactericidal activities and postantibiotic effects of macrolides antibiotics against clinical isolates, and examination of shape alteration by scanning electron microscope].
    Yano H; Kobayashi T; Okitsu N; Aoki A; Toriya M; Nakada Y; Sagai H; Iyobe S; Inoue M
    Jpn J Antibiot; 2007 Feb; 60(1):31-46. PubMed ID: 17436861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China.
    Liu X; Shen X; Chang H; Huang G; Fu Z; Zheng Y; Wang L; Li C; Liu L; Shen Y; Yang Y
    Pediatr Pulmonol; 2009 May; 44(5):436-41. PubMed ID: 19360846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptococcus pyogenes Forms Serotype- and Local Environment-Dependent Interspecies Protein Complexes.
    Chowdhury S; Khakzad H; Bergdahl GE; Lood R; Ekstrom S; Linke D; Malmström L; Happonen L; Malmström J
    mSystems; 2021 Oct; 6(5):e0027121. PubMed ID: 34581598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of penicillin-macrolide-resistant Streptococcus pyogenes among pet animals: An ongoing public health threat.
    Samir A; Abdel-Moein KA; Zaher HM
    Comp Immunol Microbiol Infect Dis; 2020 Feb; 68():101390. PubMed ID: 31760363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study.
    Farrell DJ; Morrissey I; Bakker S; Felmingham D
    J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():39-47. PubMed ID: 12239227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel RNA polymerase inhibitor found in soil extracts provides hope for future antibacterial drugs.
    Ebright RH
    Future Med Chem; 2017 Oct; 9(16):1857-1861. PubMed ID: 29076390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of macrolide resistance mechanisms in Bulgarian clinical isolates of Streptococcus pyogenes during the years of 2013-2016.
    Muhtarova AA; Gergova RT; Mitov IG
    J Glob Antimicrob Resist; 2017 Sep; 10():238-242. PubMed ID: 28735056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antibacterial activity of modithromycin, a novel 6,11-bridged bicyclolide, against respiratory pathogens, including macrolide-resistant Gram-positive cocci.
    Sato T; Tateda K; Kimura S; Iwata M; Ishii Y; Yamaguchi K
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1588-93. PubMed ID: 21220534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
    Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
    Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and characterization of macrolide resistance in clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes from North America.
    Hoban DJ
    J Chemother; 2002 Jul; 14 Suppl 3():25-30. PubMed ID: 12418558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.